Distinguished Professor, Quetelet Endowed Professor of Public Health, Associate Dean for Science, Director of Office of Energetics, and Director of the Nutrition Obesity Research Center; Authored over 450 peer-reviewed publications and five books. 2012 IOM Member. 2002 ILSI Board of Trustees. Elected Fellow ASA, APA, & AAAS. 2002 Andre Mayer Award from IASO; 2009 ASN Centrum Award; 2002 Lilly Scientific Achievement Award & 2009 TOPS Award from the Obesity Society; 2006 NSF PAESMEM Award.
Assistant Professor of Computation Genetics at Albert Einstein College of Medicine, NY.
I am a Biostatistician working in descriptive cancer epidemiology in Queensland, Australia, with a strong research interest in describing temporal and spatial patterns of cancer. My work has a particular focus on health inequalities in cancer-related outcomes. I have published over 180 peer-reviewed journal articles in addition to 20+ commissioned peer-reviewed monographs, and been a chief investigator on externally funded research grants totaling over $7million. I regularly review scientific manuscripts and grant applications for national and international funding bodies.
Dr. Berghout received her PhD in Biochemistry from McGill University in Montreal, QC where she researched the genetics of complex traits and susceptibility to infectious disease in humans and mouse models. Following that, she spent three years as the Outreach Coordinator for the Mouse Genome Informatics (MGI) database in Bar Harbor, ME. There, she trained researchers in genetics, genomics, data structures and data mining to answer biological questions, and worked closely with other members of the MGI group to develop and optimize the MGI resource. Now her research interests include genetics of all kinds, personalized medicine, big data, and scientific communication. She is currently pursuing projects in precision medicine for analysis of transcriptome data from patients with rare lung diseases (Sarcoidosis, Coccidiomycosis), and integrative network analysis of complex traits including Alzheimer's Disease. She is currently appointed at the University of Arizona's Center for Biomedical Informatics and Biostatistics (CB2) and The Center for Genetics and Genomic Medicine (TCG2M) in Tucson, AZ.
Chris Brown is a clinical trial bio-statistician at the NHMRC Clinical Trails Centre at the University of Sydney. His main area of expertise is in oncology trials but also has experience in cardiology and neonatal research. His main areas of research are in pharmacoepidemiology and statistical methods.
Associate Research Professor of Statistics & Biostatistics at Rutgers University, with adjunct appointments in the Dept of Genetics and the Center of Alcohol Studies. Particular interest in how statistics is applied, especially in biology, medicine, and particularly human genetics
Associate Professor Biostatistics and Informatics Colorado School of Public Health; Associate Chair for Research Biostatistics and Informatics; Director Colorado Biostatistics Consortium; Director Clinical and Translational Science Institute Biostatistics, Epidemiology and Research Design Program; Theme Chair, Biostatistics Special Interest Group, Association for Clinical and Translational Science
Head of Human and Comparative Genomics Laboratory in the Biodesign Institute at Arizona State University. Affiliated faculty with the Center for Evolution and Medicine, ASU.
My research is at the interface of genetics, statistics, and software development. I am primarily interested in developing statistical models to estimate evolutionary process from large, genomic datasets. Currently most of my research is connected to mutations.
Assistant Professor of Biostatistics, Mayo Clinic. Ph.D., University of Pennsylvania. My research concerns the development and application of powerful and robust statistical methods for high-dimensional "omics" data, arising from modern high-throughput technologies such as microarray and next-generation sequencing. I am particularly interested in methods for microbiome sequencing data. Much of this effort is motivated by ongoing collaborations in projects that study the role of the human microbiome in disease pathogenesis using metagenomic sequencing.
Research interests include statistical genetics, genomics and metagenomics; and high-dimensional statistics.
Gary has research interests primarily focussed on statistical (and reporting) aspects in developing and validating multivariable prediction models. He has published over 100 papers on clinical trials, observational studies, systematic reviews, quality of life, propensity scores and prediction models.
Gary is a statistical editor ("hanging committee") for the BMJ.
Gary also led the development of the TRIPOD Statement for reporting clinical prediction models - www.tripod-statement.org.
Xiangqin Cui is an associate professor in the Biostatistics Department, Section on Statistical Genetics, at University of Alabama at Birmingham. She received her Ph.D in Genetics at Iowa State University in 2001 and a three-year postdoctoral training in statistical genetics at the Jackson Laboratory afterwards. Her research is on experimental design and data analyses of high-throughput experiments including microarray, next-generation sequencing, statistical genetics/genomics, epigenomics.
Dr Martin Daumer: Director of the SLCMSR e.v. - The Human Motion Institute in Munich and managing director of the IT company, Trium Analysis Online GmbH. He is also visiting lecturer for Telemedicine and Clinical Applications of Computational Medicine at the Technical University Munich.
Dr Daumer received a diploma in Physics in 1990 and a Ph.D. in mathematics from the Ludwig-Maximilians-University Munich in 1995, after having worked at CERN, Switzerland, and Rutgers University, USA.